Nutritional Basis for Colonization Resistance by Human Commensal Escherichia coli Strains HS and Nissle 1917 against E. coli O157:H7 in the Mouse Intestine
Open accessThe DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Abstract
Escherichia coli is a single species consisting of many biotypes, some of which are commensal colonizers of mammals and others that cause disease. Humans are colonized on average with five commensal biotypes, and it is widely thought that the commensals serve as a barrier to infection by pathogens. Previous studies showed that a combination of three pre-colonized commensal E. coli strains prevents colonization of E. coli O157:H7 in a mouse model (Leatham, et al., 2010, Infect Immun 77: 2876-7886). The commensal biotypes included E. coli HS, which is known to successfully colonize humans at high doses with no adverse effects, and E. coli Nissle 1917, a human commensal strain that is used in Europe as a preventative of traveler's diarrhea. We hypothesized that commensal biotypes could exert colonization resistance by consuming nutrients needed by E. coli O157:H7 to colonize, thus preventing this first step in infection. Here we report that to colonize streptomycin-treated mice E. coli HS consumes six of the twelve sugars tested and E. coli Nissle 1917 uses a complementary yet divergent set of seven sugars to colonize, thus establishing a nutritional basis for the ability of E. coli HS and Nissle 1917 to occupy distinct niches in the mouse intestine. Together these two commensals use the five sugars previously determined to be most important for colonization of E. coli EDL933, an O157:H7 strain. As predicted, the two commensals prevented E. coli EDL933 colonization. The results support a model in which invading pathogenic E. coli must compete with the gut microbiota to obtain the nutrients needed to colonize and establish infection; accordingly, the outcome of the challenge is determined by the aggregate capacity of the native microbiota to consume the nutrients required by the pathogen.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This is likely due to ecological stability of the human gut microbiota and exclusion of incoming new bacteria through a phenomenon termed colonization resistance26.”
From Developing a new class of engineered live bacterial therapeutics to treat human diseases (2020) · cites this paper as [26]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products
Datsenko, K. A., & Wanner, B. L. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.120163297 · Cited by 14,782 · cited 7×
“Null alleles were constructed in E. coli Nissle 1917 by using the Lambda Red allelic replacement system, first described by Datsenko and Wanner [39].”
InfluentialDiarrheagenic Escherichia coli
Nataro, J. P., & Kaper, J. B. (1998) · Clinical Microbiology Reviews · doi:10.1128/cmr.11.1.142 · Cited by 5,006
Frank, D. N., St. Amand, A. L., Feldman, R. A., Boedeker, E. C., Harpaz, N., & Pace, N. R. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706625104 · Cited by 4,611 · cited 1×
“Collectively, the human gut microbiota consists of 1,000 to 36,000 different species of bacteria [7], although the number in any one individual is thought to be between 500 and 1,000 species [8].”
Resource Competition and Community Structure.
Harper, J. L., & Tilman, D. (1983) · The Journal of Ecology · doi:10.2307/2259756 · Cited by 4,180 · cited 1×
“The GI tract is comparable to a chemostat in that the contents constantly turn over and to be successful in this highly competitive environment, an organism must reproduce at least as fast as the turnover rate or it will fail to colonize [1,2].”
Resource Competition and Community Structure
Hassell, M. P., & Tilman, D. (1984) · The Journal of Animal Ecology · doi:10.2307/4549 · Cited by 4,176
Resource competition and community structure.
Tilman, D. G. (1982) · PubMed · Cited by 3,281
Culture Medium for Enterobacteria
Neidhardt, F. C., Bloch, P. L., & Smith, D. F. (1974) · Journal of Bacteriology · doi:10.1128/jb.119.3.736-747.1974 · Cited by 2,958 · cited 1×
“For confirmation of phenotypes, putative mutant strains and their wild type parents were grown in 3-N-morpholino propanesulfonic acid (MOPS) defined minimal medium [56] with 0.”
Development of the Human Infant Intestinal Microbiota
Palmer, C., Bik, E. M., DiGiulio, D. B., Relman, D. A., & Brown, P. O. (2007) · PLoS Biology · doi:10.1371/journal.pbio.0050177 · Cited by 2,877 · cited 1×
“coli and other facultative anaerobes are the first colonizers of the infant gut [13,14].”
Phosphoenolpyruvate:carbohydrate phosphotransferase systems of bacteria
Postma, P. W., Lengeler, J. W., & Jacobson, G. R. (1993) · Microbiological Reviews · doi:10.1128/mmbr.57.3.543-594.1993 · Cited by 1,903 · cited 16×
“via the mannose phosphotransferase system, ManXYZ, which has a broad substrate specificity that includes N-acetylglucosamine [42].”
InfluentialDarfeuille-Michaud, A., Boudeau, J., Bulois, P., Neut, C., Glasser, A.-L., Barnich, N., Bringer, M.-A., Swidsinski, A., Beaugerie, L., & Colombel, J.-F. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.04.061 · Cited by 1,566 · cited 1×
“coli has been associated with Crohn’s disease [21,22].”
Besselink, M. G., van Santvoort, H. C., Buskens, E., Boermeester, M. A., van Goor, H., Timmerman, H. M., Nieuwenhuijs, V. B., Bollen, T. L., van Ramshorst, B., Witteman, B. J., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60207-x · Cited by 1,367
Developmental microbial ecology of the neonatal gastrointestinal tract
Mackie, R. I., Sghir, A., & Gaskins, H. R. (1999) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/69.5.1035s · Cited by 1,360
The fundamental basis of inflammatory bowel disease
Strober, W., Fuss, I., & Mannon, P. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30587 · Cited by 1,319 · cited 1×
“In addition to enteric infections, disruptions in the gut microbiota have been indicated in inflammatory bowel disease [19,20], and overgrowth of certain adherent and invasive E.”
Kruis, W., Frič, P., Pokrotnieks, J., Lukáš, M., Fixa, B., Kaščák, M., Kamm, M. A., Weismueller, J., Beglinger, C., Stolte, M., et al. (2004) · Gut · doi:10.1136/gut.2003.037747 · Cited by 1,285 · cited 2×
“Nissle 1917 is also effective in maintaining remission in ulcerative colitis patients as traditional treatments [28,29,54], possibly through the increased production of indole [55].”
Rembacken, B., Snelling, A., Hawkey, P., Chalmers, D., & Axon, A. (1999) · The Lancet · doi:10.1016/s0140-6736(98)06343-0 · Cited by 1,101 · cited 1×
“Nissle 1917 is also effective in maintaining remission in ulcerative colitis patients as traditional treatments [28,29,54], possibly through the increased production of indole [55].”
Rasko, D. A., Rosovitz, M. J., Myers, G. S. A., Mongodin, E. F., Fricke, W. F., Gajer, P., Crabtree, J., Sebaihia, M., Thomson, N. R., Chaudhuri, R., et al. (2008) · Journal of Bacteriology · doi:10.1128/jb.00619-08 · Cited by 879 · cited 3×
“E. coli HS was obtained from David Rasko at the University of Maryland [33].”
InfluentialLevine, M., Nalin, D., Hornick, R., Bergquist, E., Waterman, D., Young, C., Sotman, S., & Rowe, B. (1978) · The Lancet · doi:10.1016/s0140-6736(78)90299-4 · Cited by 685 · cited 3×
“It is considered a true human commensal, colonizing humans strongly (10 10 CFU/g feces) with no sign of disease [32].”
BackgroundInfluentialGenetics of Lactase Persistence and Lactose Intolerance
Swallow, D. M. (2003) · Annual Review of Genetics · doi:10.1146/annurev.genet.37.110801.143820 · Cited by 591
The role of microbiota in infectious disease
Stecher, B., & Hardt, W.-D. (2008) · Trends in Microbiology · doi:10.1016/j.tim.2007.12.008 · Cited by 535 · cited 1×
“It is becoming increasingly apparent that a better understanding of the role of the commensal microbiota in CR is needed in order to effectively treat and prevent disease [23,24].”
Carbon nutrition of Escherichia coli in the mouse intestine
Chang, D.-E., Smalley, D. J., Tucker, D. L., Leatham, M. P., Norris, W. E., Stevenson, S. J., Anderson, A. B., Grissom, J. E., Laux, D. C., Cohen, P. S., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307888101 · Cited by 512 · cited 4×
“This strategy for the study of intestinal colonization has been used extensively by our group [9,11,12,25,26,45,46,57,58].”
InfluentialSelf-citationTurnbaugh, P. J., Quince, C., Faith, J. J., McHardy, A. C., Yatsunenko, T., Niazi, F., Affourtit, J., Egholm, M., Henrissat, B., Knight, R., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1002355107 · Cited by 478 · cited 1×
“Collectively, the human gut microbiota consists of 1,000 to 36,000 different species of bacteria [7], although the number in any one individual is thought to be between 500 and 1,000 species [8].”
Zyrek, A. A., Cichon, C., Helms, S., Enders, C., Sonnenborn, U., & Schmidt, M. A. (2007) · Cellular Microbiology · doi:10.1111/j.1462-5822.2006.00836.x · Cited by 428 · cited 2×
“coli Nissle 1917 also has several fitness factors [30].”
Mechanisms controlling pathogen colonization of the gut
Stecher, B., & Hardt, W.-D. (2011) · Current Opinion in Microbiology · doi:10.1016/j.mib.2010.10.003 · Cited by 421 · cited 1×
“In a recent review, Stecher and Hardt explain that while the mechanisms of CR are incompletely understood, it is thought that they include direct inhibition of pathogens, the stimulation of host defenses, and nutrient depletion [15].”
Gastrointestinal microbiology enters the metagenomics era
Frank, D. N., & Pace, N. R. (2008) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e3282f2b0e8 · Cited by 405 · cited 1×
“It is becoming increasingly apparent that a better understanding of the role of the commensal microbiota in CR is needed in order to effectively treat and prevent disease [23,24].”
BackgroundThe impact of the microbiota on the pathogenesis of IBD: lessons from mouse infection models
Nell, S., Suerbaum, S., & Josenhans, C. (2010) · Nature Reviews Microbiology · doi:10.1038/nrmicro2403 · Cited by 398 · cited 1×
“In addition to enteric infections, disruptions in the gut microbiota have been indicated in inflammatory bowel disease [19,20], and overgrowth of certain adherent and invasive E.”
Fabich, A. J., Jones, S. A., Chowdhury, F. Z., Cernosek, A., Anderson, A., Smalley, D., McHargue, J. W., Hightower, G. A., Smith, J. T., Autieri, S. M., et al. (2008) · Infection and Immunity · doi:10.1128/iai.01386-07 · Cited by 380 · cited 18×
“hexuronates, mannose, N-acetylglucosamine, ribose, and sucrose for colonization [25].”
InfluentialSelf-citationTRANSPLANT OR CHEMOTHERAPY IN ACUTE MYELOGENOUS LEUKAEMIA
(1989) · The Lancet · doi:10.1016/s0140-6736(89)92393-3 · Cited by 377
Lambda Red-mediated recombinogenic engineering of enterohemorrhagic and enteropathogenic E. coli
Murphy, K. C., & Campellone, K. G. (2003) · BMC Molecular Biology · doi:10.1186/1471-2199-4-11 · Cited by 371
Freter, R., Brickner, H., Botney, M., Cleven, D., & Aranki, A. (1983) · Infection and Immunity · doi:10.1128/iai.39.2.676-685.1983 · Cited by 339 · cited 2×
“The GI tract is comparable to a chemostat in that the contents constantly turn over and to be successful in this highly competitive environment, an organism must reproduce at least as fast as the turnover rate or it will fail to colonize [1,2].”
Heterogeneity of Enteroaggregative Escherichia Coli Virulence Demonstrated
Nataro, J. P., Yikang, D., Cookson, S., Cravioto, A., Savarino, S. J., Guers, L. D., Levine, M. M., & Tacket, C. O. (1995) · Journal of Infectious Diseases · doi:10.1093/infdis/171.2.465 · Cited by 326 · cited 2×
“coli and Salmonella strains due to its ability to consistently colonize the intestine in high numbers [32,48,49,50].”
Survival and Implantation of Escherichia coli in the Intestinal Tract
Freter, R., Brickner, H., Fekete, J., Vickerman, M. M., & Carey, K. E. (1983) · Infection and Immunity · doi:10.1128/iai.39.2.686-703.1983 · Cited by 318 · cited 1×
“Freter noted several factors that contribute to colonization success, and concluded that the most important is competition for resources, which led to the nutrient-niche hypothesis: in order to successfully colonize in the absence of adhesion to the mucosal surface an organism must use at least one limiting nutrient b…”
Lapaquette, P., Glasser, A.-L., Huett, A., Xavier, R. J., & Darfeuille-Michaud, A. (2010) · Cellular Microbiology · doi:10.1111/j.1462-5822.2009.01381.x · Cited by 313 · cited 1×
“coli has been associated with Crohn’s disease [21,22].”
Clinical use of E. coli Nissle 1917 in inflammatory bowel disease
Schultz, M. (2008) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20377 · Cited by 310 · cited 2×
“Nissle 1917 is also effective in maintaining remission in ulcerative colitis patients as traditional treatments [28,29,54], possibly through the increased production of indole [55].”
What’s for Dinner?: Entner-Doudoroff Metabolism in Escherichia coli
Peekhaus, N., & Conway, T. (1998) · Journal of Bacteriology · doi:10.1128/jb.180.14.3495-3502.1998 · Cited by 288
Self-citationLeatham, M. P., Banerjee, S., Autieri, S. M., Mercado-Lubo, R., Conway, T., & Cohen, P. S. (2009) · Infection and Immunity · doi:10.1128/iai.00059-09 · Cited by 232
Self-citationRespiration of Escherichia coli in the Mouse Intestine
Jones, S. A., Chowdhury, F. Z., Fabich, A. J., Anderson, A., Schreiner, D. M., House, A. L., Autieri, S. M., Leatham, M. P., Lins, J. J., Jorgensen, M., et al. (2007) · Infection and Immunity · doi:10.1128/iai.00484-07 · Cited by 223 · cited 3×
“This strategy for the study of intestinal colonization has been used extensively by our group [9,11,12,25,26,45,46,57,58].”
Self-citationEXPERIMENTAL SHIGELLA INFECTIONS: CHARACTERISTICS OF A FATAL INFECTION PRODUCED IN GUINEA PIGS
Formal, S. B., Dammin, G. J., LaBrec, E. H., & Schneider, H. (1958) · Journal of Bacteriology · doi:10.1128/jb.75.5.604-610.1958 · Cited by 176 · cited 1×
“coli HS was first isolated in 1958 from a healthy human volunteer during a study of Shigella flexneri [31].”
Continuous-flow cultures as in vitro models of the ecology of large intestinal flora
Freter, R., Stauffer, E., Cleven, D., Holdeman, L. V., & Moore, W. E. (1983) · Infection and Immunity · doi:10.1128/iai.39.2.666-675.1983 · Cited by 166
Wells, C. L., Maddaus, M. A., Reynolds, C. M., Jechorek, R. P., & Simmons, R. L. (1987) · Infection and Immunity · doi:10.1128/iai.55.11.2689-2694.1987 · Cited by 154 · cited 1×
“Streptomycin is taken up by actively respiring cells and therefore selectively removes facultative anaerobic bacteria in the gut [63,64].”
Anaerobic Respiration of Escherichia coli in the Mouse Intestine
Jones, S. A., Gibson, T., Maltby, R., Chowdhury, F. Z., Stewart, V. J., Cohen, P. S., & Conway, T. (2011) · Infection and Immunity · doi:10.1128/iai.05395-11 · Cited by 147 · cited 3×
“This strategy for the study of intestinal colonization has been used extensively by our group [9,11,12,25,26,45,46,57,58].”
Self-citationMiranda, R. L., Conway, T., Leatham, M. P., Chang, D. E., Norris, W. E., Allen, J. H., Stevenson, S. J., Laux, D. C., & Cohen, P. S. (2004) · Infection and Immunity · doi:10.1128/iai.72.3.1666-1676.2004 · Cited by 133
Self-citationGlycogen and Maltose Utilization by Escherichia coli O157:H7 in the Mouse Intestine
Jones, S. A., Jorgensen, M., Chowdhury, F. Z., Rodgers, R., Hartline, J., Leatham, M. P., Struve, C., Krogfelt, K. A., Cohen, P. S., & Conway, T. (2008) · Infection and Immunity · doi:10.1128/iai.00096-08 · Cited by 130 · cited 2×
“This strategy for the study of intestinal colonization has been used extensively by our group [9,11,12,25,26,45,46,57,58].”
Self-citationExperimental and Mathematical Models of Escherichia coli Plasmid Transfer In Vitro and In Vivo
Freter, R. R., Freter, R. R., & Brickner, H. (1983) · Infection and Immunity · doi:10.1128/iai.39.1.60-84.1983 · Cited by 115 · cited 1×
“Freter noted several factors that contribute to colonization success, and concluded that the most important is competition for resources, which led to the nutrient-niche hypothesis: in order to successfully colonize in the absence of adhesion to the mucosal surface an organism must use at least one limiting nutrient b…”
Leatham, M. P., Stevenson, S. J., Gauger, E. J., Krogfelt, K. A., Lins, J. J., Haddock, T. L., Autieri, S. M., Conway, T., & Cohen, P. S. (2005) · Infection and Immunity · doi:10.1128/iai.73.12.8039-8049.2005 · Cited by 93 · cited 2×
“This strategy for the study of intestinal colonization has been used extensively by our group [9,11,12,25,26,45,46,57,58].”
Self-citationBryan, A. B., Roesch, P. L., Davis, L. M., Moritz, R. L., Pellett, S., & Welch, R. A. (2006) · Infection and Immunity · doi:10.1128/iai.74.2.1072-1083.2006 · Cited by 85
LeDoux, D., LaBombardi, V. J., & Karter, D. (2006) · International Journal of STD & AIDS · doi:10.1258/095646206776253507 · Cited by 81 · cited 1×
“The authors noted that although patients with incomplete gut microbiota have been the successful targets for probiotic treatment, cases have arisen where probiotics were associated with sepsis and other adverse effects, especially in immunocompromised patients [35,36,37,38].”
Gronbach, K., Eberle, U., Müller, M., Ölschläger, T. A., Dobrindt, U., Leithäuser, F., Niess, J. H., Döring, G., Reimann, J., Autenrieth, I. B., et al. (2010) · Infection and Immunity · doi:10.1128/iai.00218-10 · Cited by 62 · cited 1×
“coli Nissle 1917 was able to translocate through the epithelial layer, leading to dissemination, septicemia, and death of the animals [34].”
PLUMBRIDGE, J. A. (2009) · Journal of Bacteriology · doi:10.1128/jb.00448-09 · Cited by 59
Leatham-Jensen, M. P., Frimodt-Møller, J., Adediran, J., Mokszycki, M. E., Banner, M. E., Caughron, J. E., Krogfelt, K. A., Conway, T., & Cohen, P. S. (2012) · Infection and Immunity · doi:10.1128/iai.06193-11 · Cited by 59
Self-citationEXPERIMENTAL MODELS IN THE INVESTIGATION OF THE VIRULENCE OF DYSENTERY BACILLI AND ESCHERICHIA COLI*
Formal, S. B., DuPont, H. L., Hornick, R. B., Snyder, M. J., Libonati, J. P., & LaBrec, E. H. (1971) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1971.tb35004.x · Cited by 58
Models for Studying the Role of Bacterial Attachment in Virulence and Pathogenesis
Freter, R. R., & Jones, G. W. (1983) · Clinical Infectious Diseases · doi:10.1093/clinids/5.supplement_4.s647 · Cited by 55 · cited 1×
“Freter noted several factors that contribute to colonization success, and concluded that the most important is competition for resources, which led to the nutrient-niche hypothesis: in order to successfully colonize in the absence of adhesion to the mucosal surface an organism must use at least one limiting nutrient b…”
Autieri, S. M., Lins, J. J., Leatham, M. P., Laux, D. C., Conway, T., & Cohen, P. S. (2007) · Infection and Immunity · doi:10.1128/iai.00822-07 · Cited by 54
Self-citationA SITE OF ACTION OF STREPTOMYCIN
Umbreit, W. W. (1949) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)57014-9 · Cited by 53
Determination of colonization resistance of the digestive tract by biotyping of Enterobacteriaceae
Apperloo-Renkema, H. Z., van der Waaij, B. D., & van der Waaij, D. (1990) · Epidemiology and Infection · doi:10.1017/s0950268800047944 · Cited by 48
Robins-Browne, R. M., Levine, M. M., Rowe, B., & Gabriel, E. M. D. V. F. (1982) · Infection and Immunity · doi:10.1128/iai.38.2.798-801.1982 · Cited by 38 · cited 2×
“coli and Salmonella strains due to its ability to consistently colonize the intestine in high numbers [32,48,49,50].”
Bleich, A., Sundberg, J. P., Smoczek, A., Von Wasielewski, R., De Buhr, M. F., Janus, L. M., Julga, G., Ukena, S. N., Hedrich, H., & Gunzer, F. (2008) · International Journal of Experimental Pathology · doi:10.1111/j.1365-2613.2007.00560.x · Cited by 24 · cited 1×
“The authors noted that although patients with incomplete gut microbiota have been the successful targets for probiotic treatment, cases have arisen where probiotics were associated with sepsis and other adverse effects, especially in immunocompromised patients [35,36,37,38].”
Schumann, S., Alpert, C., Engst, W., Loh, G., & Blaut, M. (2012) · Applied and Environmental Microbiology · doi:10.1128/aem.07340-11 · Cited by 20
Probiotic prophylaxis in predicted severe acute pancreatitis
Bjarnason, A., Adler, S. N., & Bjarnason, I. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61028-4 · Cited by 16 · cited 1×
“The authors noted that although patients with incomplete gut microbiota have been the successful targets for probiotic treatment, cases have arisen where probiotics were associated with sepsis and other adverse effects, especially in immunocompromised patients [35,36,37,38].”
Population Genetics of Lactase Persistence and Lactose Intolerance
Ingram, C. J. E., Liebert, A., & Swallow, D. M. (2012) · Wiley eBooks · doi:10.1002/9780470015902.a0020855.pub2 · Cited by 13
INHIBITION OF THE ANAEROBIC PYRUVATE METABOLISM OF ESCHERICHIA COLI BY DIHYDROSTREPTOMYCIN, ,
Barkulis, I. L. (1953) · Journal of Bacteriology · doi:10.1128/jb.65.3.337-343.1953 · Cited by 11
Henry, R. J., Housewright, R. D., & Berkman, S. (1949) · Journal of Bacteriology · doi:10.1128/jb.57.4.447-451.1949 · Cited by 10
[Mutaflor and its medical significance].
Nissle, A. (1951) · PubMed · Cited by 9
The Effect of Streptomycin on Oxygen Uptake and Viability of Resting Suspensions of Escherichia coli
Paine, T. F., & Clark, L. S. (1953) · Science · doi:10.1126/science.118.3055.73 · Cited by 6 · cited 1×
“Streptomycin is an aminoglycoside antibiotic that inhibits protein synthesis, affecting terminal respiration pathways, carbohydrate metabolism, and cell division [59,60,61].”
Research works printed but not linked: 3
- Hentges DJ, Que JU, Casey SW, Stein AJ (1984) The influence of streptomycin on colonization resistance in mice. Microecology and Therapy 14: 53– 62.
- Notifiable Disease and Mortality Tables. MMWR Recommendations and reports: Morbidity and mortality weekly report Recommendations and reports/Centers for Disease Control 60: 1762– 1775.
- Franklin T, Snow G (2005) Attack and defense: drug transport across cell walls and membranes. Biochemistry an Molecular Biology of Antimicrobial Drug Action. 6 ed. New York: Sringer Science+Business MEdia, Inc. pp. 121–134.
Cited by
Gut biogeography of the bacterial microbiota
Donaldson, G. P., Lee, S. M., & Mazmanian, S. K. (2016) · Nature Reviews Microbiology · doi:10.1038/nrmicro3552 · Cited by 2,535
Interactions between the microbiota and pathogenic bacteria in the gut
Bäumler, A. J., & Sperandio, V. (2016) · Nature · doi:10.1038/nature18849 · Cited by 1,420
Microbiota-liberated host sugars facilitate post-antibiotic expansion of enteric pathogens
Ng, K. M., Ferreyra, J. A., Higginbottom, S. K., Lynch, J. B., Kashyap, P. C., Gopinath, S., Naidu, N., Choudhury, B., Weimer, B. C., Monack, D. M., et al. (2013) · Nature · doi:10.1038/nature12503 · Cited by 1,035
The intestinal microbiota: Antibiotics, colonization resistance, and enteric pathogens
Kim, S., Covington, A., & Pamer, E. G. (2017) · Immunological Reviews · doi:10.1111/imr.12563 · Cited by 741
Gut Microbiota and Colonization Resistance against Bacterial Enteric Infection
Ducarmon, Q. R., Zwittink, R. D., Hornung, B. V. H., van Schaik, W., Young, V. B., & Kuijper, E. J. (2019) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00007-19 · Cited by 566
Metadata
- Authors
- Maltby, R., Leatham-Jensen, M. P., Gibson, T., Cohen, P. S., & Conway, T.
- Affiliations
- University of Oklahoma (US)
- University of Rhode Island (US)
- Corresponding author
- Conway, Tyrrell
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2013-01-17
- Volume
- 8
- Issue
- 1
- Pages
- e53957
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3547972
- OpenAlex
- W2032347305
- Cited by
- 285
- References
- 63
- Citations by year
- 2026: 21 · 2025: 24 · 2024: 22 · 2023: 26 · 2022: 33 · 2021: 24 · 2020: 25 · 2019: 16 · 2018: 16 · 2017: 23 · 2016: 16 · 2015: 17 · 2014: 13 · 2013: 9
- FWCI
- 13.02
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- SHAREOK (University of Oklahoma; Oklahoma State University; Central Oklahoma University) (submittedVersion, cc-by)
- Journal of Media Literacy Education (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Institute of General Medical Sciences (GM095370, R01GM095370)
- National Institute of Allergy and Infectious Diseases (R56AI048945, R01AI048945, AI48945)
- Topics
- Life Sciences › Immunology and Microbiology › Microbiology › Escherichia coli research studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Bacterial Genetics and Biotechnology
- Keywords
- colonization resistance, commensal Escherichia coli, Escherichia coli Nissle 1917, Escherichia coli O157:H7, EDL933, dietary sugar, nutrient competition, gut microbiota, mouse intestine, pathogen colonization
- MeSH terms
- Animals, Anti-Bacterial Agents, Escherichia coli, Escherichia coli Infections, Feces, Genetic Complementation Test, Humans, Intestines, Male, Mutation, Streptomycin, Ecosystem, Escherichia coli O157, Carbohydrate Metabolism, Mice, Host-Pathogen Interactions, Bacterial Load
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.